HempAmericana, Inc

Equities

HMPQ

US42370P2074

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 03:40:57 2024-07-12 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2020	Hempamericana, Inc Launches New and Improved Ecommerce Sales Platform	CI
2019	HempAmericana, Inc. Readies Launch of Online Payment Processing System Following Positive CBD Lab Results	CI

HempAmericana Enters Smokable Hemp Flower Market with November Branded Product Launch

October 03, 2019 at 10:22 am EDT

HempAmericana Inc. announced the upcoming launch of its new Smokable Hemp Flower product line. The Company will launch the new product in November 2019, with full packaging and distribution arrangements currently being negotiated.

Latest news about HempAmericana, Inc

Hempamericana, Inc Launches New and Improved Ecommerce Sales Platform	20-04-02	CI
HempAmericana, Inc. Readies Launch of Online Payment Processing System Following Positive CBD Lab Results	19-12-11	CI
HempAmericana Signs LOI with Smart Decision for CBD-Based Algorithmic Product Recommendation System	19-11-20	CI
Hempamericana Commences Significant Online CBD Sales Activity Following Launch of Ecommerce Portal	19-11-06	CI
HempAmericana Enters Smokable Hemp Flower Market with November Branded Product Launch	19-10-03	CI
HempAmericana, Inc. Adds High-Capacity Solvent Recovery System ahead of Company’s Commercial Distribution	19-07-01	CI
HempAmericana Announces Final Production Machinery and Timing for Initial Commercial Shipments	19-06-19	CI
HempAmericana, Inc. Announces Purchase Order Agreement with Eagle Hemp	19-06-10	CI
Hempamericana Announces New Agreement to Become Principal Supplier for Florida-Based CBD Brand	19-06-05	CI
HempAmericana, Inc. Commences Bottling on Full Spectrum Distillate CBD in Maine Laboratory	19-05-13	CI
Hempamericana, Inc Announces Purchase Order for CBD Distillate; Expands its Production Capacity At Augusta and Maine	19-01-22	CI
HempAmericana Upgrades CBD Quality and Output Capacity at Primary Facility Ahead of Full-Scale Production	18-12-04	CI
HempAmericana, Inc Estimates $1 Million Revenue Yield from First Hemp Harvest At Union Farm Facility	18-11-26	CI
HempAmericana, Inc Commences Processing Hemp Flower at CBD Production Facility	18-11-12	CI
HempAmericana, Inc. Readies to Launch Its Own Proprietary CBD Oil	18-10-31	CI
HempAmericana Completes Construction of High-Potency Seed Augmentation Greenhouse	18-06-07	CI
HempAmericana Begins Bottling and Distribution Phase for 99% Pure CBD Isolate Production	18-05-17	CI
HempAmericana, Inc. Acquires 4,000 Lbs of High-Quality Hemp Flower for Processing at New Fully Operational CBD Oil Extraction and Production Facility in Augusta, Maine	18-05-10	CI
HempAmericana, Inc. Secures Initial Hemp Material with Potential CBD Oil Sales Yield of $20 Million	18-04-12	CI
HempAmericana Considers Acquisitions	18-03-15	CI
HempAmericana Inc. Announces Production Assembly to Begin on 200L Super Critical CO2 Extractor Machine	17-11-20	CI
HempAmericana, Inc Purchases 200L Supercritical Co2 Extractor to Begin Mass Production	17-09-14	CI
HempAmericana Inc. Announces Management Changes	14-08-18	CI
HempAmericana, Inc Auditor Raises 'Going Concern' Doubt	14-04-07	CI

Chart HempAmericana, Inc

Duration

Period

More charts

Company Profile

HempAmericana, Inc. is a developmental stage company, which is engaged in research, development and selling of products made of hemp. The Company focuses on the development of cannabidiol (CBD). The Company serves customers in health, food, construction, textiles, and paper industries. The Company also intends to invest in factories that use decorticators, machines designed to strip the fibers from the hemp plant, as well as additional machines that can produce the valuable CBD oil from the hemp plant.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
HEMPAMERICANA, INC	0.00%	3.02K
MODERNA, INC.	+22.10%	46.55B
LONZA GROUP AG	+46.45%	41.84B
IQVIA HOLDINGS INC.	-3.12%	40.84B
ALNYLAM PHARMACEUTICALS, INC.	+36.10%	32.95B
CELLTRION, INC.	-6.30%	28.27B
ICON PUBLIC LIMITED COMPANY	+18.71%	27.78B
UNITED THERAPEUTICS CORPORATION	+46.15%	14.26B
MEDPACE HOLDINGS, INC.	+44.52%	13.69B
BIO-TECHNE CORPORATION	+0.19%	12.18B

Other Biotechnology & Medical Research